Isomorphic Labs
Adrian Stecuła is a Research Leader in Cheminformatics at Isomorphic Labs since December 2022, previously serving as the Director of Discovery Chemistry at Atomwise from March 2018 to November 2022. Earlier roles at Atomwise included Principal Scientist, Senior Scientist, and Scientist. Adrian's academic journey includes a postdoctoral fellowship at UCSF under Kathleen Giacomini, and graduate studies focused on the structure and function of SLC transporters and kinases. Educational qualifications encompass a Ph.D. in Pharmaceutical Sciences and Pharmacogenomics from UCSF, a Master of Engineering in Pharmaceutical Development from the University of Michigan, and a Bachelor's degree in Chemical Engineering from the same institution. Experience also includes an internship at Boehringer Ingelheim and research positions at various universities, reflecting a strong foundation in pharmaceutical and biomedical sciences.
Isomorphic Labs
7 followers
Isomorphic Labs is a new Alphabet company and commercial venture which aims to reimagine the entire drug discovery process from first principles with an AI-first approach, and, ultimately, to model and understand some of the fundamental mechanisms of life. Using computational advances, we’re working at the cutting edge in the new era of ‘digital biology’. By significantly increasing the pace of scientific research and efficacy of new medicines, we will be at the forefront of breakthroughs that will benefit millions of people.